Bausch & Lomb has acquired eyeonics, the maker of the crystalens accommodating IOL.
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
How patients navigate quality-of-life challenges associated with geographic atrophy
Investigators sought to understand the diagnostic path, symptoms, quality of life impact and coping mechanisms of patients with GA in western Europe and the United States
Higher Molar Dose and Its Translation into Clinical Practice
EyeCool Therapeutics announces results from pilot study of novel chronic ocular surface pain treatment
The investigational device, ETX-4143, was the focus of a study involving 31 patients with COSP in Australia
Retinal microvascular changes in patients with systemic lupus erythematosus: Importance of OCTA
The biomarkers are especially crucial for patients with lupus nephritis
Topcon Healthcare, Inc. appoints Krysten Williams Head of Digital Solutions & Clinical Development – EMEA
Williams joins Topcon Healthcare from Heidelberg Engineering, where she held multiple senior leadership roles.
Bausch + Lomb's LuxLife IOL receives CE Mark approval
The LuxLife full range of vision intraocular lens is available in a range of cylinders spanning from +0.75D to +6.00D.